As LPA activates a number of tyrosine kinase receptors by increasing the rates of release of the cell-surface-tethered growth factors (Mills and Moolenaar, 2003), it is possible that LPA receptors promote breast cancer progression through the transactivation of cell-surface tyrosine kinase receptors. The gene discussed is NTRK1; the disease is breast carcinoma.